Juno, Millennium settle patent dispute over cancer drug Velcade

Intellectual Property 2019-09-30 11:56 am By Miklos Bolza | Sydney

Please login to bookmark

Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication Velcade.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au